NYLI Candriam U.S. Mid Cap Equity ETF Rating $38.94 +0.20 (+0.52%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock NYLI Candriam U.S. Mid Cap Equity ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IQSM Aggregate RatingModerate Buy 2.73Holdings in IQSM have an aggregate rating of Moderate Buy based on 444 analyst ratings issued in the past year covering 25 companies (19.7% of the portfolio).IQSM Aggregate Price Target$38.94High Prediction$38.94Average Prediction$38.94Low Prediction$38.94Holdings in IQSM have an aggregate price target of $38.94 and a range of $38.94 to $38.94 covering 25 companies (19.7% of the portfolio).IQSM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by NYLI Candriam U.S. Mid Cap Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IQSM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.28%RVMDRevolution Medicines$189.23+0.3%1.8255 of 5 stars2.95$144.67 -23.5%22News CoveragePositive NewsAnalyst Forecast1.07%TWLOTwilio$191.43+3.4%4.2531 of 5 stars3.00$219.23 14.5%26Positive News0.96%NVTnVent Electric$151.51-4.6%4.9576 of 5 stars3.18$190.57 25.8%17News CoveragePositive NewsUpcoming EarningsAnalyst Forecast0.95%OKTAOkta$138.50+1.8%3.339 of 5 stars2.64$121.81 -12.1%44Positive News0.91%FFIVF5$392.21+1.1%3.4657 of 5 stars2.55$382.67 -2.4%11Positive NewsUpcoming Earnings0.90%CHRWC.H. Robinson Worldwide$186.51-9.2%4.6056 of 5 stars2.67$199.46 6.9%24News CoveragePositive NewsUpcoming EarningsAnalyst ForecastGap DownHigh Trading Volume0.89%MKSIMKS$329.18-4.7%4.6213 of 5 stars2.81$385.00 17.0%16Positive NewsAnalyst Forecast0.88%MRNAModerna$54.07-5.2%1.5742 of 5 stars1.82$40.00 -26.0%17Upcoming EarningsAnalyst Forecast0.88%USFDUS Foods$97.17+1.7%4.2921 of 5 stars2.67$107.00 10.1%15News CoveragePositive NewsAnalyst Forecast0.86%BURLBurlington Stores$349.62+3.0%2.7004 of 5 stars2.74$353.56 1.1%19News CoveragePositive NewsAnalyst Downgrade0.82%GHGuardant Health$147.33-1.9%3.1621 of 5 stars2.96$160.04 8.6%25News CoveragePositive NewsUpcoming Earnings0.73%MTSIMACOM Technology Solutions$266.99-5.6%4.6683 of 5 stars2.93$330.45 23.8%14News CoveragePositive NewsAnalyst Forecast0.73%VTRSViatris$17.24-0.2%2.5451 of 5 stars2.57$17.50 1.5%7Analyst Upgrade0.69%ROKURoku$141.97+0.2%3.0269 of 5 stars2.37$155.13 9.3%27Trending NewsUpcoming Earnings0.68%LSCCLattice Semiconductor$128.42-7.0%3.5531 of 5 stars2.87$132.29 3.0%15News Coverage0.68%SNXTD SYNNEX$243.06-2.0%4.9634 of 5 stars3.00$294.67 21.2%10Positive NewsAnalyst Revision0.67%KIMKimco Realty$26.09+1.3%2.3844 of 5 stars2.53$26.12 0.1%17News CoveragePositive NewsAnalyst Forecast0.67%STRLSterling Infrastructure$660.93-7.9%3.7967 of 5 stars3.13$720.67 9.0%8Positive News0.65%BBYBest Buy$85.26+1.0%4.2093 of 5 stars2.14$79.50 -6.8%22Positive News0.65%NBIXNeurocrine Biosciences$175.77+0.9%4.682 of 5 stars2.96$194.05 10.4%23News CoveragePositive NewsUpcoming EarningsAnalyst Forecast0.65%NLYAnnaly Capital Management$22.43+0.5%3.9645 of 5 stars2.75$24.33 8.5%12Trending NewsEarnings ReportAnalyst Forecast0.64%IEXIDEX$223.13+0.4%4.4527 of 5 stars2.67$244.00 9.4%9News CoveragePositive NewsUpcoming EarningsAnalyst Forecast0.64%BALLBall$63.84+2.6%4.4411 of 5 stars2.77$70.85 11.0%13Positive News0.62%ITTITT$195.78+0.3%4.7858 of 5 stars2.92$234.75 19.9%12Positive News0.62%MASMasco$79.32+2.6%4.0827 of 5 stars2.47$80.67 1.7%19Positive NewsUpcoming Earnings This page (NYSEARCA:IQSM) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NYLI Candriam U.S. Mid Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share NYLI Candriam U.S. Mid Cap Equity ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IQSM Stock Alerts